Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Fox

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 15, 2020
Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography in the Assessment and Management of Stable Chest Pain: Rationale and Design of the FORECAST TrialMichael Mahmoudi, Zoe Nicholas, Jacqui Nuttall, et al.
International Journal of Cardiology|July 22, 2014
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registryMichal Tendera, Kim Fox, Roberto Ferrari, et al.
European Heart Journal|March 29, 2013
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trialsKim Fox, Michel Komajda, Ian Ford, et al.
The American Journal of Medicine|June 6, 2015
Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunctionVictoria Hamill, Ian Ford, Kim Fox, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 11, 2020
Simple risk models to predict cardiovascular death in patients with stable coronary artery diseaseIan Ford, Michele Robertson, Nicola Greenlaw, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 6, 2005
A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosisLutz Hamann, Abuzeid Gomma, Nicolas W J Schröder, et al.
Journal of the American College of Cardiology|August 28, 2007
Resting heart rate in cardiovascular diseaseKim Fox, Jeffrey S Borer, A John Camm, et al.
European Heart Journal|August 31, 2018
Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatmentRoberto Ferrari, Rita Pavasini, Paolo G Camici, et al.
Clinical Cardiology|February 22, 2019
Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention studyDeepak L Bhatt, Kim Fox, Robert A Harrington, et al.
Nature Reviews. Cardiology|September 8, 2017
Expert consensus document: A 'diamond' approach to personalized treatment of anginaRoberto Ferrari, Paolo G Camici, Filippo Crea, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 15, 2020
Fractional Flow Reserve Derived from Computed Tomography Coronary Angiography in the Assessment and Management of Stable Chest Pain: Rationale and Design of the FORECAST TrialMichael Mahmoudi, Zoe Nicholas, Jacqui Nuttall, et al.
International Journal of Cardiology|July 22, 2014
Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registryMichal Tendera, Kim Fox, Roberto Ferrari, et al.
European Heart Journal|March 29, 2013
Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trialsKim Fox, Michel Komajda, Ian Ford, et al.
The American Journal of Medicine|June 6, 2015
Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunctionVictoria Hamill, Ian Ford, Kim Fox, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|January 11, 2020
Simple risk models to predict cardiovascular death in patients with stable coronary artery diseaseIan Ford, Michele Robertson, Nicola Greenlaw, et al.
Journal of Molecular Medicine (Berlin, Germany)|May 6, 2005
A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosisLutz Hamann, Abuzeid Gomma, Nicolas W J Schröder, et al.
Journal of the American College of Cardiology|August 28, 2007
Resting heart rate in cardiovascular diseaseKim Fox, Jeffrey S Borer, A John Camm, et al.
European Heart Journal|August 31, 2018
Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatmentRoberto Ferrari, Rita Pavasini, Paolo G Camici, et al.
Clinical Cardiology|February 22, 2019
Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention studyDeepak L Bhatt, Kim Fox, Robert A Harrington, et al.
Nature Reviews. Cardiology|September 8, 2017
Expert consensus document: A 'diamond' approach to personalized treatment of anginaRoberto Ferrari, Paolo G Camici, Filippo Crea, et al.
Pageof 7